Tonix Pharmaceuticals Holding Corp. (TNXP)

Latest News

View all news

Apr 1, 2024

Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights

Mar 28, 2024

Tonix Pharmaceuticals Announces Pricing of $4.4 Million Registered Direct Offering

Mar 25, 2024

Tonix Pharmaceuticals Receives Rare Pediatric Disease Designation from the FDA for TNX-2900 for the Treatment of Prader-Willi Syndrome

View all news

Investor Presentation April 2024

View Presentation

2024 Annual Meeting of Shareholders

View Event Add to Calendar View All Events

Latest Financial Results

FY 2023

Fiscal Year Ended Dec 31, 2023

Earnings Release

10-K

PDF HTML

XBRL

ZIP XLS HTML

Latest Annual Filing

For Fiscal Year Ending Dec 31, 2023

IR Contacts

Company

Tonix Pharmaceuticals Holding Corp.
26 Main Street
Suite 101
Chatham, NJ 07928
T: 862-799-8599
investor.relations@tonixpharma.com

Investor Relations

TONIX Pharmaceuticals
investor.relations@tonixpharma.com

Transfer Agent

VStock Transfer, LLC
77 Spruce Street
Suite 201
Cedarhurst, NY 11516
T: 212-828-8436
https://www.vstocktransfer.com

Market Data copyright © 2024 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.